An agent having progesterone antagonist properties may be used to treat eye conditions associated with pathological blood vessel formation, for example age-related macular degeneration, choroidal neovascularisation, retinal neovascularisation or corneal neovascularisation. The agent may be mifepristone.
申请公布号
WO2008078095(A1)
申请公布日期
2008.07.03
申请号
WO2007GB04947
申请日期
2007.12.21
申请人
SUMMIT (CAMBRIDGE) LTD.;RICHARDS, FRANCES, MARGARET;ROACH, ALAN, GEORGE
